Hollandbio Calls for Enhanced Biotech Innovation Climate in the Netherlands
Amsterdam, Wednesday, 26 November 2025.
Hollandbio emphasizes the need for better-aligned funding to boost the Netherlands as a biotech innovation hub, crucial for economic growth and public health.
The Imperative for Innovation in Biotech
In the face of increasing global competition, Hollandbio, the Dutch biotech industry association, stresses the urgent need for a more supportive innovation climate in the Netherlands. This call to action is driven by the recognition that a robust biotech sector is not only pivotal for economic growth but also for advancing public health. By advocating for improved funding mechanisms, Hollandbio aims to remove the financial hurdles that currently impede biotech entrepreneurs from focusing on innovation [1].
Enhancing the Biotech Ecosystem
Hollandbio’s program, ‘IJzersterk Innovatieklimaat,’ seeks to create a fertile environment for biotech companies by focusing on three main pillars: capital, knowledge, and infrastructure. These elements are designed to ensure that the Netherlands remains a top destination for biotech innovation. The program emphasizes the need for clear, swift, and certain pathways for industry leaders, alongside financial structures that align with the unique needs of biotech entrepreneurs. This approach is intended to shift the focus from procedural navigation to product development and market entry [1][2].
Leadership and Strategic Vision
The strategic push is led by Dora Menting, Program Manager, and Robbert Wever, Project Manager at Hollandbio. Based in The Hague, South Holland, Hollandbio represents a diverse community of over 280 member companies, ranging from startups to multinationals. Their advocacy is crucial in addressing the regulatory and financial challenges that threaten to stall innovation within the sector [1][3].
Broader Economic and Health Implications
The importance of a thriving biotech sector extends beyond the industry’s borders, influencing broader economic and health outcomes. Innovations in biotechnology can lead to the development of new medicines, sustainable food sources, and environmentally friendly materials. This not only enhances the quality of life but also ensures that the Netherlands can maintain its competitive edge in the global market. As Hollandbio continues to advocate for these changes, they underscore the need for a proactive approach to innovation that aligns with the country’s economic and health priorities [1][3].